The Novel, Nicotinic Alpha7 Receptor Partial Agonist, BMS-933043, Improves Cognition and Sensory Processing in Preclinical Models of Schizophrenia-Reference-Cited by-同舟云学术

The Novel, Nicotinic Alpha7 Receptor Partial Agonist, BMS-933043, Improves Cognition and Sensory Processing in Preclinical Models of Schizophrenia

Published:2016-07-28 Issue:7 Volume:11 Page:e0159996
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Bristow Linda J.,Easton Amy E.,Li Yu-Wen,Sivarao Digavalli V.,Lidge Regina,Jones Kelli M.,Post-Munson Debra,Daly Christopher,Lodge Nicholas J.,Gallagher Lizbeth,Molski Thaddeus,Pieschl Richard,Chen Ping,Hendricson Adam,Westphal Ryan,Cook James,Iwuagwu Christiana,Morgan Daniel,Benitex Yulia,King Dalton,Macor John E.,Zaczek Robert,Olson Richard

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference49 articles.

1. Longitudinal assessment of premorbid cognitive functioning in patients with schizophrenia through examination of standardized scholastic test performance;R Fuller;Am J Psychiatry,2002

2. Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS;MF Green;Schizophrenia Research,2004

3. Cognitive deficits as treatment targets in schizophrenia;J Gold;Schizophrenia Research,2004

4. Recent advances in treating cognitive impairment in schizophrenia;C Galletly;Psychopharmacology (Berl),2009

5. Molecular and cellular mechanisms of action of nicotine in the CNS;J Barik;Handbook of Experimental Pharmacology,2009

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neutral or Detrimental Effects of TREM2 Agonist Antibodies in Preclinical Models of Alzheimer’s Disease and Multiple Sclerosis;The Journal of Neuroscience;2024-06-03

2. Click-train evoked steady state harmonic response as a novel pharmacodynamic biomarker of cortical oscillatory synchrony;Neuropharmacology;2023-12

3. Click-train evoked steady state harmonic response as a novel pharmacodynamic biomarker of cortical oscillatory synchrony;2023-07-19

4. A phase 1b/2a multicenter study of the safety and preliminary pharmacodynamic effects of selective muscarinic M ₁ receptor agonist HTL0018318 in patients with mild‐to‐moderate Alzheimer's disease;Alzheimer's & Dementia: Translational Research & Clinical Interventions;2022-01

5. Cognitive Deficit in Schizophrenia: From Etiology to Novel Treatments;International Journal of Molecular Sciences;2021-09-14